RSV's anti‐inflammatory properties further contribute to AMD management by reducing levels of pro‐inflammatory cytokines and chemokines implicated in AMD‐related inflammation, including interleukin‐6 (IL‐6), interleukin‐8 (IL‐8), and C‐X‐C motif chemokine 11 (CXCL11) [47, 48]. The gene discussed is CXCL8; the disease is age-related macular degeneration.